Recent exploration of cancer biomarkers hidden within urine or blood exosomes that provide fundamental information for future cancer diagnostics (Diagnostics, 2025)
In academia-industry collaboration, Dr. Hara’s work focuses on the early detection of cancer, the mechanisms by which cancer cells evade growth controls such as contact inhibition, and the significance of early detection for effective treatment. The integration of next-generation sequencing technology for detailed gene expression analysis and the potential use of exosomes as cancer markers highlight the evolving approaches in cancer diagnostics.